Pursuant to SEBI Circular No. HO/38/11(2)/2026-MIRSD-POD/1/3750/2026 dated February 05, 2026, Syschem (India) has informed that a special window has been opened for re-lodgement of transfer requests for shares for a period of one year, from February 05, 2026 to February 04, 2027, in order to facilitate ease of investing for investors and to safeguard their rights in respect of securities purchased by them. In this regard, the Company has published an advertisement in the newspapers to create awareness among the investors about the aforesaid special window. A copy of the said newspaper advertisement is enclosed.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: